Novel therapy for the treatment
of malignant Melanoma
Potential for an effective therapy for malignant melanoma that reduces tumour size with minimal systemic side effects and scarring, at a fraction of the cost of current immune based treatments.
Our mission
We are on a mission to revolutionise the treatment of melanoma skin cancer using our patented Klas-PDT technology.
Clinicians
Supporting clinicians to deliver better outcomes for their patients.
Patients
Providing a more effective melanoma treatment with significantly reduced side effects.
Technology
We use cutting-edge Photodynamic Therapy technology in our solution.
Our mission
We are on a mission to revolutionise the treatment of melonoma skin cancer using our patentable Klas-PDT technology.
Clinicians
Supporting clinicians to deliver better outcomes for their patients.
Patients
Providing a more effective melanoma treatment with significantly reduced side effects
Technology
We use cutting-edge Photodynamic Therapy technology in our solution.
Supported by
Our Science
Learn more about how KLAS-PDT works by watching our short explainer video. Our unique compound allows photodynamic therapy (PDT) to be effective against malignant melanoma for the first time, complimenting the current treatment offerings against this deadly cancer.
Our Science
Learn more about how KLAS-PDT works by watching our short explainer video. Our unique compound allows photodynamic therapy (PDT) to be effective against malignant melanoma for the first time, complimenting the current treatment offerings against this deadly cancer.
News
Investment Opportunities
KLAS Therapeutics is actively seeking investors who want to make a real difference in the lives of Melanoma sufferers and become a part of a dynamic team that seeks to push the boundaries of current medical therapies.